Page 55 - Pharma

Mylan buys Famy Care businesses for $750 mn

The acquisition will provide Mylan with an enhanced and vertically integrated platform that will accelerate the company's growth in the important global women's health care space

Lupin receives USFDA nod for diarrhoea drug vancomycin

Vancomycin hydrochloride capsule is the a generic version of ANI Pharmaceuticals' Vancocin capsules, which had annual US sales of $164 mn

Divis Laboratories plans Rs 500-cr facility in Andhra Pradesh

This will be its third facility, which is expected to be located at Kakinada

US FTC grants conditional approval for Sun-Ranbaxy merger deal

Two companies have agreed to divest Ranbaxy's interest in generic minocycline tablets to Torrent Pharmaceuticals in order to seek FTC's final nod for their $4-bn merger deal

Solvay sells Germany-based refrigerants business to Daikin

This marks the exit of Solvay from the refrigerants market

Sanofi invests Rs 90 cr in Apollo Sugar Clinics

Sanofi-Synthelabo India, a part of pharma major Sanofi group, will invest Rs 90 crore in ASCL through a combination of primary and secondary funding

Weakening of Euro to affect India's exports: FIEO

While most of the economies were contracting and deflation was being witnessed, the Greek verdict has added economic uncertainties in Europe, which account for about 18.5% of India's exports

Strides Arcolab receives USFDA's nod for Bangalore facility

USFDA, which inspected the facility in August 2014, has found Strides Arcolab's oral dosage facility acceptable

Sanofi begins work on Rs 460-cr insulin facility in Hyderabad

This will be Sanofi's second plant aside from its existing Insuman (human insulin) manufacturing plant in Frankfurt (Germany)

'Brain drain' concern from developing countries is misplaced

'Indirect' learning in mature markets crucial to the growth of firms from developing countries such as India, according to a research at Cambridge Judge Business School, UK

Biotech industry to grow to $100 bn by 2025: ABLE

The Association of Biotechnology Led Enterprises (ABLE) seeks extension of 10-year tax holiday for biotech/farming establishments by another 2 years

BASF increases vitamin A production capacity

The company has expanded its capacity for vitamin A by 25% in Ludwigshafen, Germany

Max India to demerge specialty films business

This follows the decision of Max India to split the company into three verticals - life insurance, health & allied business, and specialty films

Gilead expands licensing pact with Indian firms for hepatitis C drug

Amendment will result in inclusion of investigational pan-genotypic agent in the agreement signed by the US firm with eight Indian companies in September 2014

BASF to invest Euro 56 mn to expand polyvinylpyrrolidone capacities

The company will increase its global PVP production capacities by up to 6,000 metric tonnes

IPCA Labs receives USFDA's import alert for MP plant

The company had voluntarily suspended API shipments from its Ratlam (MP) facility for the US market, after it received Form FDA 483 from USFDA in July 2014

Beryl Drugs bags MP govt's order to supply medicines

As per the pact, the company will receive Rs 11.80 crores from MPPHSCL, which will boost up its turnover by 60-65%

Dr Reddy's arm Aurigene inks pact with US firm Curis

Collaboration has been formed to discover, develop and commercialise small molecule antagonists for immuno-oncology and precision oncology targets

Emami buys Australia's Fravin to strengthen personal care biz

The acquisition is expected to give Emami a foothold in the natural and organic personal care market, pegged globally at nearly Rs 47,000 crore

US court rules against Natco Pharma in a patent case

The US Supreme Court has reportedly ruled in favour of Teva over patent for multiple sclerosis drug Copaxone